We are live on !
Find out more
Profund Advisors Portfolio holdings
AUM
$3.48B
Turnover
14.37%
1-Year Est. Return
66.96%
ProFund Advisors manages the ProFunds mutual funds, which include index funds across sectors, bonds, currencies and crypto, as well as leveraged and inverse funds. The ProFunds brand dates from 1997, and its affiliate ProShares began offering leveraged and inverse ETFs in 2006. The Bitcoin ProFund tracks bitcoin futures rather than holding bitcoin itself.
This Fund
S&P 500
This Quarter Est. Return
+3.6%
1 Year Est. Return
+66.96%
3 Year Est. Return
+258.11%
5 Year Est. Return
+342.15%
10 Year Est. Return
+1,333.1%
AUM
$3.48B
AUM Growth
-$153M
(-4.2%)
Cap. Flow
-$155M
Cap. Flow % of AUM
Cap. Flow %
-4.44%
Top 10 Holdings %
Top 10 Hldgs %
41.36%
Holding
1,225
New
50
Increased
319
Reduced
729
Closed
126
Avg Time Held
6.2
years
Top 10 Avg Time Held
4.5
years
Top 20 Avg Time Held
5.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$37.8M |
| 2 |
Alumis Inc
ALMS
|
+$2.98M |
| 3 |
Collegium Pharmaceutical
COLL
|
+$1.65M |
| 4 |
Reddit
RDDT
|
+$1.57M |
| 5 |
Septerna Inc
SEPN
|
+$1.45M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$46.8M |
| 2 |
Broadcom
AVGO
|
+$15.2M |
| 3 |
Micron Technology
MU
|
+$13.3M |
| 4 |
Apple
AAPL
|
+$12.8M |
| 5 |
Advanced Micro Devices
AMD
|
+$10.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 54.2% |
| 2 | Healthcare | 10.88% |
| 3 | Communication Services | 8.15% |
| 4 | Consumer Discretionary | 7.38% |
| 5 | Industrials | 4.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
301
Arcutis Biotherapeutics
ARQT
$3.48B
| $1.31M | 0.04% |
49,700
+8,045
| +19% | +$210K |
2024 Q1
10 quarters
|
|
302
CRH
CRH
$62.5B
| $1.31M | 0.04% |
15,810
-4,626
| -23% | -$443K |
2025 Q4
3 quarters
|
|
303
Corteva
CTVA
$6.13B
| $1.28M | 0.04% |
16,525
-9,953
| -38% | -$824K |
2019 Q2
29 quarters
|
|
304
Equinix
EQIX
$106B
| $1.28M | 0.04% |
1,266
+270
| +27% | +$281K |
2013 Q2
53 quarters
|
|
305
Beam Therapeutics
BEAM
$2.49B
| $1.28M | 0.04% |
52,359
+4,775
| +10% | +$133K |
2021 Q3
20 quarters
|
|
306
Harrow
HROW
$1.06B
| $1.28M | 0.04% |
41,532
+33,810
| +438% | +$1.32M |
2025 Q3
4 quarters
|
|
307
Enliven Therapeutics
ELVN
$3.56B
| $1.28M | 0.04% |
27,874
+20,148
| +261% | +$1.1M |
2025 Q4
3 quarters
|
|
308
Nucor
NUE
$58.7B
| $1.28M | 0.04% |
5,461
-2,531
| -32% | -$633K |
2013 Q2
53 quarters
|
|
309
Vulcan Materials
VMC
$36B
| $1.27M | 0.04% |
5,200
-1,809
| -26% | -$492K |
2022 Q4
15 quarters
|
|
310
Infosys
INFY
$49.8B
| $1.27M | 0.04% |
118,207
-6,668
| -5% | -$76.8K |
2013 Q2
53 quarters
|
|
311
Uber
UBER
$141B
| $1.27M | 0.04% |
18,500
-2,523
| -12% | -$185K |
2023 Q4
11 quarters
|
|
312
EQT Corp
EQT
$32.8B
| $1.26M | 0.04% |
25,954
-7,091
| -21% | -$372K |
2013 Q2
53 quarters
|
|
313
MKS Inc
MKSI
$15B
| $1.25M | 0.04% |
4,719
-476
| -9% | -$141K |
2013 Q2
53 quarters
|
|
314
BeOne Medicines Ltd
ONC
$47.5B
| $1.24M | 0.04% |
3,400
-810
| -19% | -$277K |
2017 Q2
37 quarters
|
|
315
Lattice Semiconductor
LSCC
$16.9B
| $1.24M | 0.04% |
9,854
-595
| -6% | -$73.7K |
2021 Q2
21 quarters
|
|
316
Amphastar Pharmaceuticals
AMPH
$1.23B
| $1.23M | 0.04% |
47,715
+35,700
| +297% | +$772K |
2023 Q2
13 quarters
|
|
317
Martin Marietta Materials
MLM
$36.8B
| $1.22M | 0.04% |
2,545
-894
| -26% | -$479K |
2022 Q4
15 quarters
|
|
318
Shell
SHEL
$279B
| $1.22M | 0.03% |
12,795
-96
| -0.7% | -$8.66K |
2022 Q1
18 quarters
|
|
319
Zevra Therapeutics
ZVRA
$664M
| $1.2M | 0.03% |
109,547
+94,021
| +606% | +$1.11M |
2025 Q3
4 quarters
|
|
320
Medtronic
MDT
$129B
| $1.2M | 0.03% |
13,897
-404
| -3% | -$35.6K |
2013 Q2
53 quarters
|
|
321
Steel Dynamics
STLD
$33.7B
| $1.2M | 0.03% |
5,399
-1,739
| -24% | -$418K |
2013 Q2
53 quarters
|
|
322
CVS Health
CVS
$115B
| $1.19M | 0.03% |
13,885
-328
| -2% | -$32.1K |
2013 Q2
53 quarters
|
|
323
Progressive
PGR
$136B
| $1.17M | 0.03% |
5,655
+550
| +11% | +$119K |
2013 Q2
53 quarters
|
|
|
324
Alumis Inc
ALMS
$793M
| $1.17M | 0.03% |
158,249
+143,998
| +1,010% | +$2.98M |
2026 Q1
2 quarters
|
|
325
Hecla Mining
HL
$8.97B
| $1.16M | 0.03% |
68,003
-651
| -0.9% | -$11.4K |
2013 Q2
53 quarters
|
|
Similar funds
TC
SHIM
Profund Advisors's Q3 2026 Portfolio in Review
As of Q3 2026, Profund Advisors held 1,225 positions worth $3.48B, down 4.2% from $3.64B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Profund Advisors withdrew a net $155M in Q3 2026, closing 126 positions and reducing 729 holdings. Its most notable exit was Electronic Arts, an estimated $5.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 54% of assets, down from 56% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, Profund Advisors opened a new position in SpaceX worth $41.3M.
- Profund Advisors's largest Q3 2026 buy was SpaceX: 273,453 shares worth $41.3M.
- Profund Advisors added most to Alumis Inc in Q3 2026, an estimated $2.98M increase.
- Profund Advisors's biggest Q3 2026 reduction was NVIDIA, cutting an estimated $46.8M.
- Profund Advisors fully exited Electronic Arts in Q3 2026, selling an estimated $5.2M.
- Profund Advisors's ten largest holdings make up 41% of its $3.48B portfolio in Q3 2026.
- Profund Advisors opened 50 new positions and closed 126 in Q3 2026.
- Profund Advisors's portfolio value fell 4.2% quarter-over-quarter to $3.48B.
Based on Profund Advisors's 13F filing for Q3 2026, filed 29 Oct 2026.